Corporate, financial, product, speech & presentation, press release - You name it!

ESMO Immuno-Oncology Congress 2018

Jérôme Galon, co-founder of HalioDx and chairman of its Scientific Advisory Board, will present  "MSI status plus Immunoscore to select metastatic colorectal cancer patients for immunotherapies" on december the 14th at 12h30 CET.

Do not hesitate to contact us if you want to meet our team during this meeting

For more information about this event, visit the ESMO IO Website